Editorial: 365 days of progress in cancer genetics

por Ratajska, Magdalena, Sette, Claudio, Cunliffe, Heather E.
Publicado 2023

Editorial: Insight in cancer genetics: 2022

por Naro, Chiara, Cunliffe, Heather E., Sette, Claudio
Publicado 2022

Context-specific gene regulatory networks subdivide intrinsic subtypes of breast cancer

por Nasser, Sara, Cunliffe, Heather E, Black, Michael A, Kim, Seungchan
Publicado 2011

Long Non-coding RNA ANRIL in the Nucleus Associates With Periostin Expression in Breast Cancer

por Mehta-Mujoo, Paulomi M., Cunliffe, Heather E., Hung, Noelyn A., Slatter, Tania L.
Publicado 2019

Oestrogen is bad for patients with breast cancer?

por Jordan, V Craig, Ariazi, Eric A, Lewis-Wambi, Joan S, Swaby, Ramona R, Cunliffe, Heather E, Riegel, Anna T, Wellstein, Anton
Publicado 2007

In Vitro Assessment of the Inflammatory Breast Cancer Cell Line SUM 149: Discovery of 2 Single Nucleotide Polymorphisms in the RNase L Gene

por Nokes, Brandon T., Cunliffe, Heather E., LaFleur, Bonnie, Mount, David W., Livingston, Robert B., Futscher, Bernard W., Lang, Julie E.
Publicado 2013

Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer

por Katchman, Benjamin A, Ocal, I Tolgay, Cunliffe, Heather E, Chang, Yu-Hui, Hostetter, Galen, Watanabe, Aprill, LoBello, Janine, Lake, Douglas F
Publicado 2013

Correction to: Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in luminal B breast cancer

por Katchman, Benjamin A., Tolgay Ocal, I., Cunliffe, Heather E., Chang, Yu-Hui, Hostetter, Galen, Watanabe, Aprill, LoBello, Janine, Lake, Douglas F.
Publicado 2018

Activin B and Activin C Have Opposing Effects on Prostate Cancer Progression and Cell Growth

por Reader, Karen L., John-McHaffie, Simon, Zellhuber-McMillan, Sylvia, Jowett, Tim, Mottershead, David G., Cunliffe, Heather E., Gold, Elspeth J.
Publicado 2022

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer

por Barrett, Michael T., Anderson, Karen S., Lenkiewicz, Elizabeth, Andreozzi, Mariacarla, Cunliffe, Heather E., Klassen, Christine L., Dueck, Amylou C., McCullough, Ann E., Reddy, Srikanth K., Ramanathan, Ramesh K., Northfelt, Donald W., Pockaj, Barbara A.
Publicado 2015

CART-WHEEL.org: An Ethically Approved Online Database for Patient-Entered Data to Facilitate Rare Cancer Research

por Kee, Damien, Parker, Clare, Bae, Susie, Tucker, Katherine M., Harrison, Michelle, Tohidi-Esfahani, Ibrahim, Black, Marita, Delahunty, Rachel, Ananda, Sumitra, Friedlander, Michael, Cunliffe, Heather E., Gibbs, Peter, Desai, Jayesh, Trotman, Judith, Scott, Clare L.
Publicado 2020

Dephosphorylation of YB-1 is Required for Nuclear Localisation During G(2) Phase of the Cell Cycle

por Mehta, Sunali, McKinney, Cushla, Algie, Michael, Verma, Chandra S., Kannan, Srinivasaraghavan, Harfoot, Rhodri, Bartolec, Tara K., Bhatia, Puja, Fisher, Alistair J., Gould, Maree L., Parker, Kim, Cesare, Anthony J., Cunliffe, Heather E., Cohen, Scott B., Kleffmann, Torsten, Braithwaite, Antony W., Woolley, Adele G.
Publicado 2020

Deep Clonal Profiling of Formalin Fixed Paraffin Embedded Clinical Samples

por Holley, Tara, Lenkiewicz, Elizabeth, Evers, Lisa, Tembe, Waibhav, Ruiz, Christian, Gsponer, Joel R., Rentsch, Cyrill A., Bubendorf, Lukas, Stapleton, Mark, Amorese, Doug, Legendre, Christophe, Cunliffe, Heather E., McCullough, Ann E., Pockaj, Barbara, Craig, David, Carpten, John, Von Hoff, Daniel, Iacobuzio-Donahue, Christine, Barrett, Michael T.
Publicado 2012

Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)

por Ramos, Pilar, Karnezis, Anthony N, Hendricks, William P D, Wang, Yemin, Tembe, Waibhav, Zismann, Victoria L, Legendre, Christophe, Liang, Winnie S, Russell, Megan L, Craig, David W, Farley, John H, Monk, Bradley J, Anthony, Stephen P, Sekulic, Aleksandar, Cunliffe, Heather E, Huntsman, David G, Trent, Jeffrey M
Publicado 2014

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

por Reese, Jordan M, Suman, Vera J, Subramaniam, Malayannan, Wu, Xianglin, Negron, Vivian, Gingery, Anne, Pitel, Kevin S, Shah, Sejal S, Cunliffe, Heather E, McCullough, Ann E, Pockaj, Barbara A, Couch, Fergus J, Olson, Janet E, Reynolds, Carol, Lingle, Wilma L, Spelsberg, Thomas C, Goetz, Matthew P, Ingle, James N, Hawse, John R
Publicado 2014

Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors

por Necela, Brian M., Crozier, Jennifer A., Andorfer, Cathy A., Lewis-Tuffin, Laura, Kachergus, Jennifer M., Geiger, Xochiquetzal J., Kalari, Krishna R., Serie, Daniel J., Sun, Zhifu, Aspita, Alvaro Moreno, O’Shannessy, Daniel J., Maltzman, Julia D., McCullough, Ann E., Pockaj, Barbara A., Cunliffe, Heather E., Ballman, Karla V., Thompson, E. Aubrey, Perez, Edith A.
Publicado 2015

Correction: Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors

por Necela, Brian M., Crozier, Jennifer A., Andorfer, Cathy A., Lewis-Tuffin, Laura, Kachergus, Jennifer M., Geiger, Xochiquetzal J., Kalari, Krishna R., Serie, Daniel J., Sun, Zhifu, Moreno-Aspitia, Alvaro, O’Shannessy, Daniel J., Maltzman, Julia D., McCullough, Ann E., Pockaj, Barbara A., Cunliffe, Heather E., Ballman, Karla V., Thompson, E. Aubrey, Perez, Edith A.
Publicado 2015